950843-82-0

Upstream product

• 126301-19-7 (2S)-2-[(tert-butoxycarbonyl)amino]-3-phenylpropyl methanesulfonate 
• 66605-57-0 (S)-N-tert-butoxycarbonyl-2-amino-3-phenylpropanol 
• 172695-25-9 (S)-3-<(tert-butoxycarbonyl)amino>-4-phenylbutanenitrile 
• 74-88-4 methyl iodide 

Downstream Products

• 1238071-92-5 ((S)-3-amino-1-benzyl-propyl)-methyl-carbamic acid tert-buty! ester 
• 1238071-95-8 (S)-3-methylamino-4-phenyl-butyronitrile hydrochloride 
• 1312556-77-6 {(S)-1-benzyl-3-[(1-methyl-1H-pyrrole-2-carbonyl)amino]-propyl}(methyl)carbamic acid tert-butyl ester 
• 1312559-50-4 (S)-2-methoxy-N-methyl-N-(4-(1-methyl-1H-pyrrole-2-carboxamido)-1-phenylbutan-2-yl)pyrimidine-4-carboxamide 
• 1312559-48-0 (S)-2,6-dimethoxy-N-methyl-N-(4-(1-methyl-1H-pyrrole-2-carboxamido)-1-phenylbutan-2-yl)isonicotinamide 
• 1312559-13-9 (S)-2-chloro-N,6-dimethyl-N-(4-(1-methyl-1H-pyrrole-2-carboxamido)-1-phenylbutan-2-yl)isonicotinamide 
• 1312559-11-7 (S)-2-chloro-6-methoxy-N-methyl-N-(4-(1-methyl-1H-pyrrole-2-carboxamido)-1-phenylbutan-2-yl)isonicotinamide 
• 1312559-09-3 (S)-2-methoxy-N-methyl-N-(4-(1-methyl-1H-pyrrole-2-carboxamido)-1-phenylbutan-2-yl)isonicotinamide 
• 1312558-64-7 (S)-1-methyl-N-(3-(N-methyl-3-(1H-pyrrol-1-yl)benzamido)-4-phenylbutyl)-1H-pyrrole-2-carboxamide 
• 1312558-63-6 (S)-1-methyl-N-(3-(N-methyl-3-(5-methyloxazol-2-yl)benzamido)-4-phenylbutyl)-1H-pyrrole-2-carboxamide 
• 1312557-97-3 (S)-N,1-dimethyl-N-(4-(1-methyl-1H-pyrrole-2-carboxamido)-1-phenylbutan-2-yl)-1H-benzo[d][1,2,3]triazole-7-carboxamide 
• 1312557-96-2 (S)-N,2-dimethyl-N-(4-(1-methyl-1H-pyrrole-2-carboxamido)-1-phenylbutan-2-yl)-2H-indazole-4-carboxamide 
• 1312557-93-9 (S)-5-(4-fluorophenyl)-2-methyl-N-(3-(N-methylbenzofuran-4-carboxamido)-4-phenylbutyl)thiazole-4-carboxamide 
• 1312557-95-1 benzofuran-4-carboxylic acid ((S)-3-amino-1-benzylpropyl)(methyl)amide 

Relevant academic research and scientific papers

4-ARYL-BUTANE-1,3-DIAMIDES

The invention relates to compound of the formula (I): in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.

4-ARYL-BUTANE-1,3-DIAMIDES

The invention relates to compound of the formula (1) in which the substituents are as defined in the specification; m free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.